Celldex Therapeutics buy Stifel Nicolaus
Start price
26.02.26
/
50%
€26.00
Target price
26.02.27
€57.53
Performance (%)
-1.35%
Price
10.06.26
€25.25
Summary
This prediction is currently active. With a performance of -1.35%, the BUY prediction by Stifel_Nicolaus is trending in the wrong direction. This prediction currently runs until 26.02.27. The prediction end date can be changed by Stifel_Nicolaus at any time. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Celldex Therapeutics | 3.061% | 3.061% |
| iShares Core DAX® | -2,80 % | -1,40 % |
| iShares Nasdaq 100 | -6,35 % | -0,41 % |
| iShares Nikkei 225® | -6,94 % | -0,28 % |
| iShares S&P 500 | -3,41 % | 0,40 % |
Comments by Stifel_Nicolaus for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (CLDX) had its "buy" rating reaffirmed by Stifel Nicolaus. They now have a $68.00 price target on the stock, up from $58.00.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Stifel_Nicolaus for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€33.20
18.06.24
18.06.24
€54.03
18.06.25
18.06.25
-45.18%
19.06.25
19.06.25
